• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年男性无症状性传播疾病的尿白细胞酯酶筛查

Urinary leukocyte esterase screening for asymptomatic sexually transmitted disease in adolescent males.

作者信息

Werner M J, Biro F M

机构信息

Division of Adolescent Medicine, Children's Hospital Medical Center, Cincinnati, OH 45229.

出版信息

J Adolesc Health. 1991 Jun;12(4):326-8. doi: 10.1016/0197-0070(91)90008-a.

DOI:10.1016/0197-0070(91)90008-a
PMID:1907197
Abstract

The objective of this study was to evaluate the effectiveness of urinary leukocyte esterase on random urine specimens as a screening test for chlamydial and gonococcal urethral infections in asymptomatic males. Random urine specimens were obtained on 106 consecutive asymptomatic adolescent males during intake physical examination at a residential vocational training program. Results of urinary leukocyte esterase were compared to those of urethral cultures for Chlamydia trachomatis and Neisseria gonorrhoeae. Five subjects had positive chlamydia cultures, three subjects had positive gonococcal cultures, and one patient had positive cultures for both organisms. Sixteen subjects had leukocyte esterase tests reported as "trace" or greater. When compare to positive culture results for either Chlamydia or gonorrhea, urinary leukocyte esterase activity had a sensitivity of 78%, specificity of 91%, and positive predictive value of 44%. A random urine specimen for urinary leukocyte esterase activity is a cost-effective screening method for chlamydial and gonococcal urethral infections in asymptomatic adolescent males.

摘要

本研究的目的是评估随机尿液标本中尿白细胞酯酶作为无症状男性衣原体和淋菌性尿道感染筛查试验的有效性。在一个住宿职业培训项目的入学体检期间,对106名连续的无症状青少年男性采集了随机尿液标本。将尿白细胞酯酶的结果与沙眼衣原体和淋病奈瑟菌的尿道培养结果进行比较。5名受试者衣原体培养阳性,3名受试者淋菌培养阳性,1名患者两种病原体培养均阳性。16名受试者的白细胞酯酶试验报告为“微量”或更高。与衣原体或淋病的阳性培养结果相比,尿白细胞酯酶活性的敏感性为78%,特异性为91%,阳性预测值为44%。随机尿液标本检测尿白细胞酯酶活性是无症状青少年男性衣原体和淋菌性尿道感染的一种经济有效的筛查方法。

相似文献

1
Urinary leukocyte esterase screening for asymptomatic sexually transmitted disease in adolescent males.青少年男性无症状性传播疾病的尿白细胞酯酶筛查
J Adolesc Health. 1991 Jun;12(4):326-8. doi: 10.1016/0197-0070(91)90008-a.
2
Predicting Neisseria gonorrhoeae and Chlamydia trachomatis infection using risk scores, physical examination, microscopy, and leukocyte esterase urine dipsticks among asymptomatic women attending a family planning clinic in Kenya.在肯尼亚一家计划生育诊所就诊的无症状女性中,使用风险评分、体格检查、显微镜检查和白细胞酯酶尿试纸预测淋病奈瑟菌和沙眼衣原体感染。
Sex Transm Dis. 1999 Sep;26(8):476-82. doi: 10.1097/00007435-199909000-00010.
3
Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males.男性无症状衣原体和淋病奈瑟菌感染的尿液白细胞酯酶筛查试验
JAMA. 1989 Nov 10;262(18):2562-6.
4
First catch urine sediment for Chlamydia trachomatis and Neisseria gonorrhoeae culture in adolescent males with pyuria.首先采集有脓尿的青春期男性的首次晨尿沉渣,用于沙眼衣原体和淋病奈瑟菌培养。
J Adolesc Health. 1991 Jun;12(4):329-34. doi: 10.1016/0197-0070(91)90009-b.
5
Using urinary leucocyte esterase tests as an indicator of infection with gonorrhoea or chlamydia in asymptomatic males in a primary health care setting.在初级卫生保健机构中,将尿白细胞酯酶检测用作无症状男性淋病或衣原体感染的指标。
Int J STD AIDS. 2014 Feb;25(2):138-44. doi: 10.1177/0956462413495670. Epub 2013 Jul 19.
6
The value of urine specimens in screening for male urethritis and its microbial aetiologies in Tanzania.尿液标本在坦桑尼亚男性尿道炎筛查及其微生物病因学研究中的价值。
Genitourin Med. 1992 Dec;68(6):361-5. doi: 10.1136/sti.68.6.361.
7
Evaluation of urine-based screening strategies to detect Chlamydia trachomatis among sexually active asymptomatic young males.评估基于尿液的筛查策略以检测性活跃无症状年轻男性中的沙眼衣原体。
JAMA. 1993 Nov 3;270(17):2065-70.
8
Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification.重新评估核酸扩增时代尿白细胞酯酶检测的价值。
Sex Transm Dis. 1998 Jul;25(6):322-6. doi: 10.1097/00007435-199807000-00010.
9
Urine-based screening for Chlamydia trachomatis in men attending sexually transmitted disease clinics.
Sex Transm Dis. 2001 Apr;28(4):219-25. doi: 10.1097/00007435-200104000-00006.
10
Screening for Chlamydia trachomatis and Neisseria gonorrhoeae in adolescent males: value of first-catch urine examination.青少年男性沙眼衣原体和淋病奈瑟菌筛查:首次晨尿检查的价值
Lancet. 1984 Oct 27;2(8409):944-5. doi: 10.1016/s0140-6736(84)91164-4.

引用本文的文献

1
Predictive risk assessment and targeted testing could enhance STI diagnosis in a high HIV prevalence setting in Eswatini.预测性风险评估和针对性检测可提高斯威士兰艾滋病毒高流行环境下的性传播感染诊断率。
Sci Rep. 2025 Sep 29;15(1):33438. doi: 10.1038/s41598-025-19065-9.
2
Detection of Chlamydia trachomatis in an Australian high school student population.澳大利亚高中生人群中沙眼衣原体的检测
Sex Transm Infect. 2002 Jun;78(3):194-7. doi: 10.1136/sti.78.3.194.
3
Rapid screening and treatment for sexually transmitted diseases in arrestees: a feasible control measure.
对被捕者进行性传播疾病的快速筛查和治疗:一项可行的控制措施。
Am J Public Health. 1997 Sep;87(9):1423-6. doi: 10.2105/ajph.87.9.1423.
4
Current methods of laboratory diagnosis of Chlamydia trachomatis infections.沙眼衣原体感染的实验室诊断现行方法。
Clin Microbiol Rev. 1997 Jan;10(1):160-84. doi: 10.1128/CMR.10.1.160.
5
Evaluation of Sanofi Diagnostics Pasteur Chlamydia Microplate EIA shortened assay and comparison with cell culture and Syva Chlamydia MicroTrak II EIA in high- and low-risk populations.赛诺菲巴斯德衣原体微孔板酶免疫分析缩短检测法的评估及其在高风险和低风险人群中与细胞培养法及赛瓦衣原体MicroTrak II酶免疫分析的比较。
J Clin Microbiol. 1995 Nov;33(11):2839-41. doi: 10.1128/jcm.33.11.2839-2841.1995.
6
Unsatisfactory performance of the leukocyte esterase test of first voided urine for rapid diagnosis of urethritis.初段晨尿白细胞酯酶试验在尿道炎快速诊断中的表现不尽人意。
Genitourin Med. 1994 Jun;70(3):187-90. doi: 10.1136/sti.70.3.187.
7
Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males.三种免疫测定法用于检测无症状男性尿液标本中沙眼衣原体的评估。
J Clin Microbiol. 1992 Nov;30(11):2793-6. doi: 10.1128/jcm.30.11.2793-2796.1992.